Recent cognitive
imaging
papers
Dickerson
BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, Dale AM, Stern
CE,
Blacker D, Albert MS, Sperling RA. Medial temporal lobe function and
structure
in mild cognitive impairment. Ann Neurol 2004; 56: 27-35.
Editorial accompanying above paper: Grafton
ST. Doing more with less: the plight of the failing hippocampus. Ann
Neurol 2004; 56: 7-9.
Reviews
Gabrieli Nat Rev Neurosci 2004
Functional imaging & behavioral paradigms
Memory
Eldridge
et al. A dissociation of encoding and retrieval processes in the human
hippocampus. J Neurosci 2005;25(13):3280-3286.
Suppl
fig 1
Strange BA et al. J Neurosci 2002
Cog control/monitoring
Kerns
JG et al. Anterior cingulate conflict monitoring and adjustments in
control.
Science 2004;303(5660):1023-6.
Commentary
by Matsumoto & Tanaka.
Anatomical imaging
Buchanan RW et
al,
Pearlson GD. Morphometric assessment of the heteromodal association
cortex in
schizophrenia. Am J Psych 2004;161:322-331.
Ballmaier M, Toga AW, et al. Anterior cingulate, gyrus rectus, and
orbitofrontal abnormalities in elderly depressed patients: An MRI-based
parcellation of the prefrontal cortex. Am J Psych 2004;161:99-108.
Thomas
P. Naidich, Eugene Kang, Girish M. Fatterpekar, Bradley N. Delman, S.
Humayun
Gultekin, David Wolfe, Orlando Ortiz, Indra Yousry, Martin Weismann,
and Tarek
A. Yousry. The Insula: Anatomic Study and MR Imaging Display
at 1.5 T
. AJNR Am J Neuroradiol 2004 25: 222-232.
Blaizot
X, Martinez-Marcos A, Arroyo-Jimenez Md M, Marcos P, Artacho-Perula E,
Munoz M,
Chavoix C, Insausti R.The parahippocampal gyrus in the baboon:
Anatomical,
cytoarchitectonic and magnetic resonance imaging (MRI) studies. Cereb
Cortex
2004;14(3):231-246.
White matter & cerebrovascular disease/risk
Measuring
progression of cerebral white matter lesions on MRI: visual rating and
volumetrics. Prins ND, van Straaten EC, van Dijk EJ, Simoni M, van
Schijndel
RA, Vrooman HA, Koudstaal PJ, Scheltens P, Breteler MM, Barkhof F.
Neurology.
2004 May 11;62(9):1533-9.
Interaction between hypertension, apoE, and cerebral white matter
lesions. de
Leeuw FE, Richard F, de Groot JC, van Duijn CM, Hofman A, Van Gijn J,
Breteler
MM. Stroke. 2004 May;35(5):1057-60.
Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white
matter
lesions. van Dijk EJ, Prins ND, Vermeer SE, Hofman A, van Duijn CM,
Koudstaal
PJ, Breteler MM. Ann Neurol. 2004 Apr;55(4):570-5.
Magnetic resonance imaging of the brain in diabetes: the Cardiovascular
Determinants
of Dementia (CASCADE) Study. Schmidt R, Launer LJ, Nilsson LG, Pajak A,
Sans S,
Berger K, Breteler MM, de Ridder M, Dufouil C, Fuhrer R, Giampaoli S,
Hofman A;
CASCADE Consortium. Diabetes. 2004 Mar;53(3):687-92.
Type 2 diabetes and atrophy of medial temporal lobe structures on brain
MRI.
den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman
A,
Breteler MM. Diabetologia. 2003 Dec;46(12):1604-10.
Silent brain infarcts and white matter lesions increase stroke risk in
the
general population: the Rotterdam Scan Study. Vermeer SE, Hollander M,
van Dijk
EJ, Hofman A, Koudstaal PJ, Breteler MM; Rotterdam Scan Study. Stroke.
2003
May;34(5):1126-9.
Silent brain infarcts and the risk of dementia and cognitive decline.
Vermeer
SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. N Engl
J Med.
2003 Mar 27;348(13):1215-22.
Hypertension and cerebral white matter lesions in a prospective cohort
study.
de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J,
Breteler MM. Brain. 2002 Apr;125(Pt 4):765-72.
Cerebrovascular and brain morphologic correlates of mild cognitive
impairment
in the National Heart, Lung, and Blood Institute Twin Study. DeCarli C,
Miller
BL, Swan GE, Reed T, Wolf PA, Carmelli D. Arch Neurol. 2001
Apr;58(4):643-7.
Cerebral white matter lesions and subjective cognitive dysfunction: the
Rotterdam Scan Study. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A,
Jolles J,
Breteler MM. Neurology. 2001 Jun 12;56(11):1539-45.
Prevalence of cerebral white matter
lesions in
elderly people: a population based magnetic resonance imaging study.
The
Rotterdam Scan Study.
de Leeuw
FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, Hofman A,
Jolles J,
van Gijn J, Breteler MM. J Neurol Neurosurg Psychiatry. 2001
Jan;70(1):9-14.
Cerebral white matter lesions and
cognitive
function: the Rotterdam Scan Study. de Groot JC, de Leeuw FE, Oudkerk
M, van
Gijn J, Hofman A, Jolles J, Breteler MM. Ann Neurol. 2000
Feb;47(2):145-51.
Stout JC, Jernigan TL, Archibald SL, Salmon DP. Association of dementia
severity with cortical gray matter and abnormal white matter volumes in
dementia of the Alzheimer type. Arch Neurol 1996;53(8):742-9.
Genetics & imaging
Heinz A,
Romero B,
Gallinat J, Juckel G, Weinberger DR. Molecular brain
imaging and the neurobiology and
genetics of schizophrenia. Pharmacopsychiatry. 2003 Nov;36 Suppl
3:S152-7.
Review.
Hariri AR, Weinberger DR. Functional neuroimaging of genetic
variation
in serotonergic neurotransmission. Genes Brain Behav. 2003
Dec;2(6):341-9.
Review.
Hariri
AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF,
Weinberger DR.
Brain-derived neurotrophic factor val66met polymorphism affects human
memory-related hippocampal activity and predicts memory performance. J
Neurosci. 2003 Jul 30;23(17):6690-4.
Hariri
AR, Weinberger DR. Imaging genomics. Br Med Bull. 2003;65:259-70.
Review.
Egan
MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A,
Zaitsev E,
Gold B, Goldman D, Dean M, Lu B, Weinberger DR. The BDNF val66met
polymorphism affects activity-dependent secretion of BDNF and human
memory and
hippocampal function. Cell.
2003
Jan 24;112(2):257-69.
COMT & DAT
Bertolino J Neurosci 2006
Meyer-Lindenberg Nat Neurosci 2005
Blasi J Neurosci 2005
5HT transporter
Pezawas Nat Neurosci 2005
Heinz Nat Neurosci 2004
Miscellaneous
Minzenberg MJ et al. Association of
anticholinergic load with impairment of complex attention and memory in
schizophrenia. Am J Psych 2004;161:116-124.
--this article provides an
interesting
pair of indices for rating the relative anticholinergicity of various
psychotropic medications, and shows a relationship between
anticholinergic load
and psychometric performance on learning/memory and attention tasks in
schizophrenic patients.